Clinical Trials in New Hampshire (NH) | New Hampshire Clinical Drug Trials & Studies

You are viewing Clinical Trials In New Hampshire

Have multiple conditions? Click here

Showing 1-100 of 195

There are 195 trials in New Hampshire

Name	City	State	Zip
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics	Rochester	NH	03867
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease	Rochester	NH
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer	Portsmouth	NH	03801
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC	Portsmouth	NH	03801
Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma	Portsmouth	NH	03801
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only	Portsmouth	NH	03801
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Nashua	NH	03060
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Nashua	NH	03060
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Nashua	NH	03060
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Nashua	NH	03060
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Nashua	NH	03060
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer	Nashua	NH	03060
A Study in Relapse Prevention of Treatment-resistant Depression	Nashua	NH	03060
A Study in Patients With Type 2 Diabetes Mellitus	Nashua	NH	03060
A Study in Head and Neck Cancer	Nashua	NH	03060
Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome	Nashua	NH	03060
Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer	Nashua	NH	03060
Insulin Lispro 6 Days Versus Aspart 6 Days in Pump Use	Nashua	NH	03060
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)	Nashua	NH	03060
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)	Nashua	NH	03060
A Study in Patients With Rheumatoid Arthritis	Nashua	NH	03060
An Integrated Program for the Treatment of First Episode of Psychosis	Nashua	NH	03060
Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)	Nashua	NH	03060
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)	Nashua	NH	03063
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases	Manchester	NH	03103
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Manchester	NH	03103
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma	Manchester	NH	03103
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Manchester	NH	03103
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery	Manchester	NH	03103
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases	Manchester	NH	03103
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Manchester	NH	03103
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Manchester	NH	03103
Treatment Use of Generex Oral-lynâ„¢ in Patients With Diabetes	Manchester	NH	03103
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy	Manchester	NH	03103
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	Manchester	NH	03103
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery	Manchester	NH	03103
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer	Manchester	NH	03103
Redesigning Cardiac Surgery to Reduce Neurologic Injury	Manchester	NH	03102
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Manchester	NH	03102
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Manchester	NH	03102
The Dual Antiplatelet Therapy Study (DAPT Study)	Manchester	NH	03102
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Manchester	NH	03102
An Integrated Program for the Treatment of First Episode of Psychosis	Manchester	NH	03101
Testing the Helpfulness of 2 Decision Aids for Prostate Cancer	Manchester	NH	03104
Internet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans	Manchester	NH	03104
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)	Manchester	NH	03104
Group Physical Therapy for Knee Osteoarthritis	Manchester	NH	03104
The Impact of Genetic Testing for Type 2 Diabetes on Health Behaviors	Manchester	NH	03104
Cardiovascular Intervention Improvement Telemedicine Study	Manchester	NH	03104
Tiotropium Bromide in Cystic Fibrosis	Manchester	NH
Carotid Stenting vs. Surgery of Severe Carotid Artery Disease and Stroke Prevention in Asymptomatic Patients (ACT I)	Lebanon	NH	03756
Alzheimer's Disease Neuroimaging Initiative 2	Lebanon	NH	03756
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products	Lebanon	NH
The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.	Lebanon	NH
A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors	Lebanon	NH
Post-marketing, Observational Study of HUMIRAÂ® (Adalimumab) in Patients With Chronic Plaque Psoriasis (Ps)	Lebanon	NH
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib	Lebanon	NH
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC	Lebanon	NH
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study	Lebanon	NH
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs	Lebanon	NH
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor	Lebanon	NH
Study of the Safety and Efficacy of REGN727(SAR236553) in Patients With HeFH Hypercholesterolemia	Lebanon	NH
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study	Lebanon	NH
A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis	Lebanon	NH
Attain Success Trial	Lebanon	NH
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis	Lebanon	NH
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease	Lebanon	NH
4965 Post-approval Study	Lebanon	NH
4968 Post-approval Study	Lebanon	NH
nEw3 Post-approval Study	Lebanon	NH
A Study of Tocilizumab [RoActemra/Actemra] Versus Adalimumab in Patients With Rheumatoid Arthritis	Lebanon	NH
An Open-Label, 2-Cohort, Multicenter, Study of E7080 in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma	Lebanon	NH
Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder	Lebanon	NH
MP-376 (Aeroquinâ„¢, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis	Lebanon	NH
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis	Lebanon	NH
A Study of Trastuzumab-DM1 (T-DM1) Sequentially With Anthracycline-Based Chemotherapy, As Adjuvant or Neoadjuvant Therapy for Patients With Early Stage HER2-Positive Breast Cancer	Lebanon	NH
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer	Lebanon	NH
VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naive Patients With Genotype 1 Chronic Hepatitis C Virus Infection.	Lebanon	NH
RED-HFâ„¢ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial	Lebanon	NH
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer	Lebanon	NH
Phase 3 Study of Dexpramipexole in ALS	Lebanon	NH
PAVES: Pegfilgrastim Anti-VEGF Evaluation Study	Lebanon	NH
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon Î² 1a in Patients With Relapsing-Remitting Multiple Sclerosis	Lebanon	NH
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis	Lebanon	NH	03756
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION	Lebanon	NH	03756
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene	Lebanon	NH	03756
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene	Lebanon	NH	03756
Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors	Lebanon	NH	03756
GALACCTIC: A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma	Lebanon	NH	03765
Varenicline for Alcohol Dependence	Lebanon	NH	03765
Study of Immunotherapy to Treat Advanced Prostate Cancer	Lebanon	NH	03756
Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin	Lebanon	NH	03756
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients	Lebanon	NH	03756
An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency	Lebanon	NH	03756
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease	Lebanon	NH
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis	Lebanon	NH	03756
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease	Lebanon	NH
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation	Lebanon	NH	03756
Tiotropium Bromide in Cystic Fibrosis	Lebanon	NH
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab	Laconia	NH	03246

View Clinical Trial Facilities in New Hampshire

Showing 1-100 of 195